MedTrace Logo

BIIB014 Cardiovascular Monitoring Study

NCT01035515 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2010-06-22

No results posted yet for this study

Summary

The study will examine the effects of a single dose of BIIB014 on blood pressure and haemodynamic variables in healthy volunteers over 24 hours.

Conditions

  • Healthy

Interventions

DRUG

Placebo

Single dose oral capsule placebo comparator

DRUG

BIIB014 50mg

Single dose oral capsule 50mg BIIB014

DRUG

BIIB014 100mg

Single dose oral capsule 100mg BIIB014

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01035515 on ClinicalTrials.gov